FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/18/2022
Back to search
Official data from USPTO
EVIVE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
07/18/2022
Trademark type
Combined
Nice classes
5, 10, 42
Filing date
10/13/2020
Registration date
01/11/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/11/2022
Last transaction
01/11/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
24
Owner location
SG
Examiner
LEASER, ANDREW C
Law office
M80
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "EVIVE" in black next to a design of five stacked orange rectangles.
Holders and representatives
Holders
EVIVE BIOTECHNOLOGY SINGAPORE PTE. LTD.
SCIGEN PTE. LTD.
Representatives
Lisa W. Rosaya BAKER MCKENZIE LLP
Technical classification
Nice Classes
Class 5Class 10Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticals for the treatment of infectious disease and for use in oncology; medical and veterinary preparationspreparations for the treatment of infectious disease and for use in oncologydiagnostic preparations for medical purposes for detecting the presence of malignantinflammatory and autoimmune disorders and conditions and tissue trauma in humanspharmaceutical preparations for use in chemotherapypharmaceutical products for the prevention and treatment of cancerpharmaceutical preparations for the treatment of viral infections and diseasesantibacterial pharmaceuticals; pharmaceutical preparations for health careanti-inflammatory preparationsantipyretic preparationsbiological preparations for the treatment of cancermixed biological preparations for the treatment and prevention of infectious diseases
Class 10
Apparatus for medical useinsulin pumpsinsulin injectors sold emptymedical fluid injectors
Class 42
Research and development services relating to medicines; medical laboratory services; medical research; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; design of medical apparatus for others; biotechnology research; research relating to pharmaceuticals
Publications
History of USPTO decisions and trademark events.
26 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/24/2022
FIMP
FINAL DISPOSITION PROCESSED
06/24/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/11/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
01/11/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/26/2021
PUBO
PUBLISHED FOR OPPOSITION
10/26/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/06/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/18/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
09/18/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/18/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
09/18/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/18/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/19/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/18/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/18/2021
RFNT
REFUSAL PROCESSED BY IB
04/13/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/22/2021
RFRR
REFUSAL PROCESSED BY MPU
03/22/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/21/2021
CNRT
NON-FINAL ACTION WRITTEN
03/20/2021
DOCK
ASSIGNED TO EXAMINER
03/13/2021
CHLD
CHANGE OF OWNER RECEIVED FROM IB
03/05/2021
MAFR
APPLICATION FILING RECEIPT MAILED
12/08/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/04/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/03/2020
Continuous trademark protection
Get notified about every new filing that threatens EVIVE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.